Evaluation of tolvaptan-associated hepatic disorder using different national pharmacovigilance databases
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Evaluation of tolvaptan-associated hepatic disorder using different national pharmacovigilance databases ; volume:14 ; number:1 ; day:29 ; month:10 ; year:2024 ; pages:1-10 ; date:12.2024
Scientific reports ; 14, Heft 1 (29.10.2024), 1-10, 12.2024
- Creator
-
Uno, Takaya
Hosomi, Kouichi
Yokoyama, Satoshi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-77052-y
- URN
-
urn:nbn:de:101:1-2502162110068.511393937114
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Uno, Takaya
- Hosomi, Kouichi
- Yokoyama, Satoshi
- SpringerLink (Online service)
Other Objects (12)
Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases
Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases
Safety of Anthroposophic Medicinal Products: An Analysis of Adverse Drug Reactions from German Pharmacovigilance Databases
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations
Bullous pemphigoid associated with the use of dipeptidil peptidase-4 inhibitors: analysis from studies based on pharmacovigilance databases
Algorithmovigilance, lessons from pharmacovigilance
Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases
Pharmacoenvironmentology – a component of pharmacovigilance
Towards robust pharmacovigilance surveillance systems
An historical overview over Pharmacovigilance
Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases
Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases
Safety of Anthroposophic Medicinal Products: An Analysis of Adverse Drug Reactions from German Pharmacovigilance Databases
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations
Bullous pemphigoid associated with the use of dipeptidil peptidase-4 inhibitors: analysis from studies based on pharmacovigilance databases
Algorithmovigilance, lessons from pharmacovigilance
Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases
Pharmacoenvironmentology – a component of pharmacovigilance
Towards robust pharmacovigilance surveillance systems
An historical overview over Pharmacovigilance
Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases
Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases
Safety of Anthroposophic Medicinal Products: An Analysis of Adverse Drug Reactions from German Pharmacovigilance Databases
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations
Bullous pemphigoid associated with the use of dipeptidil peptidase-4 inhibitors: analysis from studies based on pharmacovigilance databases
Algorithmovigilance, lessons from pharmacovigilance
Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases
Pharmacoenvironmentology – a component of pharmacovigilance
Towards robust pharmacovigilance surveillance systems